A Binding LOI has been executed: GEDiCube will acquire 75% of Cyclomics at Closing. Expected breakthroughs by combining technologies in (early) cancer detection and recurrence of cancer with a single ...
Cell and gene therapies are rapidly becoming a staple of the therapeutic landscape for a range of diseases. Recent improvements in the accuracy, read length, and throughput offered by Oxford Nanopore ...
SAN CARLOS, Calif, Feb. 5, 2024 /PRNewswire/ -- Today, Factorial Biotechnologies, a leader in next-generation single-cell NGS solutions, unveils Mosaic ™, a groundbreaking technology poised to empower ...
By combining BioSkryb’s best-in-class single-cell amplification and multi-omic platforms with Ultima’s ultra-high-throughput, cost-efficient sequencing technology, this collaboration aims to provide ...
SAN DIEGO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower ...
There’s a lot scientists don’t know about the thousands of proteins in the human body, and protein sequences don’t tell the full story. “I'm interested in how much biological information is spatially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback